Atlas Trials

Advanced Colorectal Cancer in the Third-line Treatment and Beyond

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Colorectal Cancer in the Third-line Treatment and Beyond

RecordFirmDate
The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines. (NCT06930118)Shanghai Changzheng Hospital2025-04-10

Track Advanced Colorectal Cancer in the Third-line Treatment and Beyond automatically

Every clearance here is in the API, with alerts when new ones post.